The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells

Eljaschewitsch, Eva, Witting, Anke, Mawrin, Christian, Lee, Thomas, Schmidt, Peter M., Wolf, Susanne, Hoertnagl, Heide, Raine, Cedric S., Schneider-Stock, Regine, Nitsch, Robert, Ullrich, Oliver·2006·Neuron
DOI 10.1016/j.neuron.2005.11.027

Cited by (446)

Items 301–400 of 446

  1. Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury From SO 2 Inhalation via PPARγ Pathway
    Ben Li, Minjun Chen, Lin Guo, Yang Yun, Guangke Li, Nan Sang · 2015 · Toxicological Sciences
  2. Hormone-sensitive lipase is localized at synapses and is necessary for normal memory functioning in mice
    Cecilia Skoug, Cecilia Holm, João M. N. Duarte · 2022 · Journal of Lipid Research
  3. Cannabinoids in Periodontology: Where Are We Now?
    Yesica Andrea Carmona Rendón, Hernan Santiago Garzon, Bruno Bueno‐Silva, Roger Mauricio Arce, Lina J. Suárez · 2023 · Antibiotics
  4. Inducible Nitric Oxide Synthase Inhibition in the Medial Prefrontal Cortex Attenuates the Anxiogenic-Like Effect of Acute Restraint Stress via CB1 Receptors
    Arthur Alves Coelho, Carla Vila-Verde, Ariandra Guerini Sartim, Daniela L. Uliana, Laura A. Braga, Francisco Silveira Guimarães, Sabrina Francesca de Souza Lisboa · 2022 · Frontiers in Psychiatry
  5. (-)-Phenserine Attenuates Soman-Induced Neuropathology
    Jun Chen, Hongna Pan, Cynthia Chen, Wei Wu, Kevin Iskandar, Jeffrey He, Tetsade Piermartiri, David M. Jacobowitz, Qian‐sheng Yu, John H. McDonough et al. · 2014 · PLoS ONE
  6. Intrathecal injection of dexmedetomidine ameliorates chronic neuropathic pain via the modulation of MPK3/ERK1/2 in a mouse model of chronic neuropathic pain
    Yiling Qian, Qianlun Wang, Jiantong Jiao, Guilong Wang, Zhengfeng Gu, Dongxiao Huang, Zhiping Wang · 2019 · Neurological Research
  7. Carbon nanotube-anandamide complex exhibits sustained protective effects in an in vitro model of stroke
    Parichehr Hassanzadeh, Elham Arbabi, Fatemeh Atyabi, Rassoul Dinarvand · 2016
  8. DUSP1 regulates hippocampal damage in epilepsy rats via ERK1/2 pathway
    Li-Li Shao, Miaomiao Gao, Jing-Xin Gong, Li-Yong Yang · 2021 · Journal of Chemical Neuroanatomy
  9. Dendritic Cell Regulation by Cannabinoid-Based Drugs
    Mattias Svensson, Puran Chen, Oscar Hammarfjord · 2010 · Pharmaceuticals
  10. Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
    Ujendra Kumar · 2024 · International Journal of Molecular Sciences
  11. Spatial Transcriptomic Analysis Reveals HDAC Inhibition Modulates Microglial Dynamics to Protect Against Ischemic Stroke in Mice
    Kevin Jayaraj, Ritesh N. Kumar, Sukanya Shyamasundar, Thiruma Valavan Arumugam, Jai Santosh Polepalli, Shaikali Thameem Dheen · 2025 · Glia
  12. Dual-specificity protein phosphatase 1: A potential therapeutic target in cancer
    Suryakant K. Niture, Blaine H. M. Mooers, Dee H. Wu, Matthew Hart, Jerry Jeff Jaboin, Danushka S. Seneviratne · 2025 · iScience
  13. Crystal structure of the human dual specificity phosphatase 1 catalytic domain
    Rajesh Gumpena, G.T. Lountos, Sreejith Raran‐Kurussi, Joseph E. Tropea, Scott Cherry, David S. Waugh · 2017 · Protein Science
  14. Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential Target to Prevent Alcohol-Induced Neurodegeneration
    Daniel J. Liput, James R. Pauly, Audra L. Stinchcomb, Kimberly Nixon · 2017 · Brain Sciences
  15. Parasitic brain infection, endocannabinoids, and schizophrenia
    Robert J. Melamede · 2008 · Medical Hypotheses
  16. The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease
    Saurabh Sen, Andrew B. West · 2009 · Antioxidants and Redox Signaling
  17. Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection
    Daniele De Filippis, Antonio Steardo, Alessandra D’Amico, Caterina Scuderi, Mariateresa Cipriano, Giuseppe Esposito, Teresa Iuvone · 2009 · The Scientific World JOURNAL
  18. Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual‐specificity phosphatase MKP‐1
    Cheryl Isleib Blaukovitch, Raymond J. Pugh, Albert C. Gilotti, Daniela Kanyi, Linda J. Lowe‐Krentz · 2010 · Journal of Cellular Biochemistry
  19. From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches
    Maurizio Bifulco, Chiara Laezza, Anna Maria Malfitano · 2007 · Multiple Sclerosis Journal
  20. Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
    Colin J. Murray, Haley A. Vecchiarelli, Marie‐Ève Tremblay · 2023 · Frontiers in Aging Neuroscience
  21. The endocannabinoid system and breathing
    Beth M. Wiese, Angelica Alvarez Reyes, Todd W. Vanderah, Tally M. Largent‐Milnes · 2023 · Frontiers in Neuroscience
  22. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
    Gerwyn Morris, Ken R. Walder, Michael Berk, Andre Ferrer Carvalho, Wolfgang Marx, Chiara C. Bortolasci, Alison Ruth Yung, Basant K. Puri, Michael H. J. Maes · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  23. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
    Jon Egaña Huguet, Edgar Soria Gómez, Pedro Grandes · 2021 · International Journal of Molecular Sciences
  24. Effects of Cannabis and Cannabinoids in the Human Nervous System
    H. Kalant · 2014 · Elsevier eBooks
  25. Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention
    Syed Shahid Habib · 2017 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  26. Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation
    Qingling Kong, Songyu Tian, Chao Ma, Guonian Wang, Mingyue Zhang · 2021 · Neuroscience
  27. Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies
    A­llyn C. Howlett, Somnath Mukhopadhyay, Derek C. Norford · 2006 · Journal of Neuroimmune Pharmacology
  28. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing
    Francesca Eroli, Inge C. M. Loonen, Arn M. J. M. van den Maagdenberg, Else A. Tolner, Andrea Nistri · 2017 · Neuropharmacology
  29. Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway
    Nan Sang, Jian Zhang, Chu Chen · 2010 · Neurochemistry International
  30. Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats
    Swatabdi Kamal, Shreya Potukutchi, David J. Gelovani, Robin E. Bonomi, Srinivasu Kallakuri, John M. Cavanaugh, Thomas J. Mangner, Alana C. Conti, Ren-Shyan Liu, Renata Pasqualini et al. · 2022 · Molecular Psychiatry
  31. Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease
    Itziar Terradillos Irastorza, Itziar Bonilla‐Del Río, Nagore Puente, Maitane Serrano, Amaia Mimenza, Leire Lekunberri, Ilazki Anaut Lusar, Leire Reguero, Inmaculada Gerrikagoitia, Samuel Ruiz de Martı́n Esteban et al. · 2022 · Glia
  32. Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia
    Andreas Jäger, Maria F. Setiawan, Eva Carolina Beins, Ingo G.H. Schmidt‐Wolf, Anna Konermann · 2020 · Head & Face Medicine
  33. Ethanol downregulates N- acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms
    Fernando Morgan de Aguiar Corrêa, Andrea De Laurentiis, Ana Maria Franchi · 2016 · European Journal of Pharmacology
  34. Downstream effects of endocannabinoid on blood cells: implications for health and disease
    Valeria Gasperi, Daniela Evangelista, Isabella Savini, Domenico Del Principe, Luciana Avigliano, Mauro Maccarrone, Maria Valeria Catani · 2015 · Cellular and Molecular Life Sciences
  35. Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS
    Dorota Tomaszewska-Zaremba, Alina Gajewska, Tomasz Misztal · 2025 · International Journal of Molecular Sciences
  36. Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders
    Hyeyoung Hailey Yoon, Natasha Lillia Grimsey · 2025 · International Journal of Molecular Sciences
  37. Degalactosylated Whey Protein Suppresses Inflammatory Responses Induced by Lipopolysaccharide in Mice
    Toshio Inui, Namiko Kawamura, Riho Nakama, Akio Inui, Goro Katsuura · 2022 · Frontiers in Nutrition
  38. Lactobacillus plantarum-derived cytoplasmic membrane vesicles as novel anti-inflammatory nanotherapeutics for psoriasis management
    Yuedong Xie, Guowen Lv, Dandan Su, Manchun Li, Quanle Xu, Hongbo Chen, Fang Cheng, Dongling Dai · 2025 · Frontiers in Immunology
  39. The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma
    Alexander P. Young, Eileen M. Denovan‐Wright · 2022 · Journal of Neuroimmunology
  40. Human umbilical cord blood plasma alleviates age-related olfactory dysfunction by attenuating peripheral TNF-α expression
    Byung‐Chul Lee, Insung Kang, Seung‐Eun Lee, Jin Young Lee, Nari Shin, Jae-Jun Kim, Soon Won Choi, Kyung‐Sun Kang · 2019 · BMB Reports
  41. Cannabinoid receptors and the proconvulsant effect of toxoplasmosis in mice
    Mohammad-Mahdi Ghanbari, Marzieh Joneidi, Bahere Kiani, Jalal Babaie, Mohammad Sayyah · 2020 · Microbial Pathogenesis
  42. Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex
    Se Hyun Kim, Hyun Sook Yu, Hong Geun Park, So‐Young Park, Myoung Suk Seo, Won Je Jeon, Yong Min Ahn, Kyooseob Ha, Soon Young Shin, Yong Sik Kim · 2013 · Psychopharmacology
  43. Participation of hypothalamic CB 1 receptors in reproductive axis disruption during immune challenge
    Pablo Nicolás Surkin, María Emilia Di Rosso, Fernando Correa, Juan Carlos Elverdin, Ana Marı́a Genaro, Andrea De Laurentiis, Javier Fernández‐Solari · 2017 · Journal of Neuroendocrinology
  44. Disruption of IFN-γ–Mediated Antiviral Activity in Neurons: The Role of Cannabinoids
    R. Antonio Herrera, Joseph Hai Oved, Carol Shoshkes Reiss · 2008 · Viral Immunology
  45. Microglial cannabinoid receptor 2 and epigenetic regulation: Implications for the treatment of depression
    Pratyasha Sharma, Rajni Daksh, Saumya Khanna, Jayesh Mudgal, Shaila Angela Lewis, Devinder S Arora, Madhavan Nampoothiri · 2025 · European Journal of Pharmacology
  46. Functional characteristics, intercellular interactions and pathophysiological associations of astrocytes in Parkinson’s disease
    Ziying Li, Mengran Cao, Zhaoyang Yin, Xiaolei Li, Qinglu Wang, Panpan Dong, Caixia Zhou · 2025 · PeerJ
  47. Topical β-Caryophyllene for Dermatologic Disorders: Mechanisms, Human Evidence, and Clinical Translation
    Amina M. Bagher · 2025 · Pharmaceuticals
  48. Electroacupuncture attenuates inflammatory pain via peripheral cannabinoid receptor type 1 signaling pathway in mice
    Tsung‐Jung Ho, Ching-Fang Lin, Jhong-Kuei Chen, Yen‐Lun Kung, Li-Kung Wu, Chen-Ying Chang Chien, Chun-Ping Huang · 2023 · PLoS ONE
  49. Endocannabinoid modulation of allergic responses: Focus on the control of FcεRI-mediated mast cell activation
    Rubi Monserrat Osorio-Perez, Gabriela Rodrı́guez–Manzo, Zyanya P. Espinosa‐Riquer, Silvia Lorenia Cruz, Claudia González‐Espinosa · 2023 · European Journal of Cell Biology
  50. Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
    Gopinath Krishnan, Nivedita Chatterjee · 2015 · Scientific Reports
  51. Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists
    Priyadharishini Veeraraghavan, Andrea Nistri · 2015 · Neuroscience
  52. Cannabinoids and GI Disorders: Endogenous and Exogenous
    Zachary Wilmer Reichenbach, Ron Schey · 2016 · Current Treatment Options in Gastroenterology
  53. Cell–cell communication by Endocannabinoids during Immune Surveillance of the Central Nervous System
    Oliver Ullrich, Regine Schneider‐Stock, Frauke Zipp · 2006 · Springer eBooks
  54. Glial Cells and the Neurobiology of Addiction
    Diane M. P. Lawrence, David A. Thomas, Da-Yu Wu · 2007 · The Scientific World JOURNAL
  55. Fatty acid binding proteins and their involvement in anxiety and mood disorders
    Matthew Jones, Taygun C. Uzuneser, Steven R. Laviolette · 2025 · Neurobiology of Disease
  56. Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro
    Alexander P. Young, Anna-Maria Szczesniak, Karolynn Hsu, Melanie E.M. Kelly, Eileen M. Denovan‐Wright · 2024 · ACS Pharmacology & Translational Science
  57. The effect of cannabinoid type 2 receptor agonist on morphine tolerance
    Di Cui, Yuanyuan Zhang, Mingyue Zhang · 2023 · IBRO Neuroscience Reports
  58. El sistema cannabinoide en situaciones de neuroinflamación: perspectivas terapéuticas en la esclerosis múltiple
    Leyre Mestre, Fernando Correa, Fabián Docagne, Diego Clemente, Silvia Ortega‐Gutiérrez, Ángel Arévalo‐Martín, Eduardo Molina‐Holgado, José Borrell Andrés, Carmen Guaza Rodríguez · 2006 · Revista de Neurología
  59. Endocannabinoids and Their Synthetic Analogs
    Kiran V. Vemuri, Alexandros Makriyannis · 2008 · Humana Press eBooks
  60. Neuroglia in anxiety disorders
    Robin E. Bonomi, Robert H. Pietrzak, Kelly Cosgrove · 2025 · Handbook of clinical neurology
  61. Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
    Louise Collins, Aisling M. Gavin, Sinéad Walsh, Aideen M. Sullivan, Sean L. Wyatt, Gerard W. O’Keeffe, Yvonne M. Nolan, André Toulouse · 2014 · SpringerPlus
  62. The Endocannabinoid System and Human Brain Functions
    John C. Ashton, Megan J. Dowie, Michelle Glass · 2017 · Elsevier eBooks
  63. Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis
    Anu Chinnadurai, Geraint Berger, Ian Burkovskiy, Juan Zhou, Ashley R. Cox, Mary Lynch, Christine Lehmann · 2019 · Medical Hypotheses
  64. The role of cannabinoid ligands in neurodegenerative diseases: Emerging anti-inflammatory, immunomodulation and disease-modifying perspectives
    Gabriela Mantovani Baldasso, Rodrigo Sebben Paes, A. F. Moreira, Sofia Gallo Salvadori, Christian Limberger, Fiorentina Roviezzo, Raffaele Capasso, Rafael Cypriano Dutra · 2026 · Pharmacological Research
  65. Dynamic endocannabinoid-mediated neuromodulation of retinal circadian circuitry
    Deepak Kumar, Bareera Khan, Yagmur Okcay, Çağıl ÖNAL SİS, Aya Abdallah, Fiona Murray, Ashish Sharma, Maiko T. Uemura, Rajeev Taliyan, Thomas Heinbockel et al. · 2024 · Ageing Research Reviews
  66. Supraphysiological Testosterone Levels Shorten the QT Interval but do Not Alter Total Anatomic Myocardial Infarct Size in Rabbits with Acute Myocardial Infarction
    Michael J. Herring, S. Hale, Jian-Ru Shi, Peyman Mesbah Oskui, G. L. Kay, R. Kloner · 2014 · Cardiovascular Pharmacology Open Access
  67. Cannabinoid Receptors and Their Signaling Mechanisms
    Balapal S. Basavarajappa · 2017 · Elsevier eBooks
  68. Mitogen-activated protein kinase phosphatase-1 (MKP-1): a critical regulator of innate immune responses
    Hongbo Chi, Anton M. Bennett, Richard Anthony Flavell · 2006 · Journal of Organ Dysfunction
  69. N-Acylethanolamines in cancer: mechanisms and therapeutic potential of lipid regulators of tumor behavior
    M F Nanì, M.M. Rinaldi, M. Miraglia, K. Rivet Amico, Paola De Cicco, Barbara Romano · 2025 · Progress in Lipid Research
  70. Endocannabinoid basis of personality—Insights from animal model of social behavior
    Natalya M. Kogan, Dilorom Begmatova, Liudmila Vinnikova, Sergey Malitsky, Maxim Itkin, Eyal Sharon, Artem Klinov, Jonathan Gorelick, Igor E. Koman, Zvi Vogel et al. · 2023 · Frontiers in Pharmacology
  71. Glial Modulation in Pain States: Translation into Humans
    Ryan J. Horvath, Edgar Alfonso Romero-Sandoval, Joyce A. De Leo · 2010 · Europe PMC (PubMed Central)
  72. The Endocannabinoid System in Local and Systemic Inflammation
    Melanie E. M. Kelly, Christine Lehmann, Juan Zhou · 2017 · Colloquium Series on Integrated Systems Physiology From Molecule to Function
  73. Effects of a CB2 Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia
    Yaliang Tang, Barbara Wolk, Debra A. Kendall · 2021 · Journal of Cellular Signaling
  74. Characterization of Subtype Selective Cannabinoid CB2 Receptor Agonists as Potential Anti-Inflammatory Agents
    Yaliang Tang, Barbara Wolk, Ryan Nolan, Caitlin E. Scott, Debra A. Kendall · 2021 · Pharmaceuticals
  75. Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids
    John C. Ashton · 2011 · Degenerative Neurological and Neuromuscular Disease
  76. A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro
    Priyadharishini Veeraraghavan, Ana Dekanic, Andrea Nistri · 2016 · Neuroscience
  77. Aplicaciones de los cannabinoides en glaucoma
    Sergio Pinar‐Sueiro, R. Rodríguez-Puertas, Elena Vecino · 2011 · Archivos de la Sociedad Española de Oftalmología
  78. The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses
    Anastasiia Kiprina, Tom Teichmann, Virna Margarita Martín Giménez, XU Wen-qing, Fiona K. Sailer, Maike Windbergs, Walter A. Manucha, Andreas Weigert, Ralf Peter Brandes · 2024 · Frontiers in Pharmacology
  79. Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration
    Daniel K. Fowler, Tylor M. Savage, Duncan Ian Mackie · 2026 · Journal of Cannabis Research
  80. The Modulated Role of Toxoplasma gondii on Eosinophils in Psychiatric Disorders after Cannabis Cessation
    Bruno Roméo, Valentine Lestra, Catherine Martelli, Ammar Amirouche, Amine Benyamina, Nora Hamdani · 2023 · Pathogens
  81. Targeting dysfunctional endocannabinoid signaling in a mouse model of Gulf War illness
    Erica Squire, Hye-Lim Lee, Woojin Jeong, Sumin Lee, V. Ravichandiran, Charles L. Limoli, Daniele Piomelli, Vipan Kumar Parihar, Kwang‐Mook Jung · 2024 · Neuropharmacology
  82. In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse
    Domokos Máthé, Ildikó Horváth, Krisztián Szigeti, Sean R. Donohue, Victor William Pike, Zisheng Jia, Catherine A. Ledent, Miklós Palkovits, Tamás F. Freund, Christer Halldin et al. · 2013 · Brain Research Bulletin
  83. Therapeutic Potential of Cannabinoids
    Guy A. Cabral, Melissa Jamerson · 2014 · Springer eBooks
  84. Erratum: Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
    Gopinath Krishnan, Nivedita Chatterjee · 2015 · Scientific Reports
  85. Shorter life- and health-span, disturbed insulin-like growth factor signalling in cannabinoid receptor type-1 knockout mice
    András Bilkei‐Gorzó · 2025 · Experimental Gerontology
  86. Downregulation of dual-specificity phosphatase 1 (DUSP1) in post-mortem brain white matter in progressive multiple sclerosis
    Martí Oró-Nolla, Melody Cui Sun, Thomas P. Reilly, Julia Anandarajah, Almudena Otálora-Alcaraz, Lisa Costelloe, HUGH F. KEARNEY, Richard Magee, Yvonne M. Nolan, Eric J. Downer · 2026 · Neurological Sciences
  87. Bovine milk fat globule size-dependent membrane lipid heterogeneity underlies its differential effects on regulating fat digestion and neuron proliferation activity
    Zhiyuan Ma, Jun Wang, Xueying Mao · 2026 · Food Bioscience
  88. Neuroprotective Strategies in Excitotoxic Brain Injury: Potential Applications to the Preterm Brain
    Elke Griesmaier, Matthias Keller · 2009 · Future Neurology
  89. Interactions between the immune and nervous systems
    Trevor John Kilpatrick, Richard M. Ransohoff, Steve L Wesselingh · 2009 · Cambridge University Press eBooks
  90. Microglia:
    Jarrott Bevyn, Apricò Karina · 2009 · Cambridge University Press eBooks
  91. Role of anandamide in Alzheimer's disease
    Dina Medina Vera, Simone Tambaro · 2024 · Elsevier eBooks
  92. Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma
    Lakshmi PK, Rajesh Singh Pawar, Yogesh Kumar Katare, M. S. Sudheesh · 2025 · ACS Pharmacology & Translational Science
  93. Endocannabinoids and Alzheimer's disease
    Chu Chen · 2025 · Handbook of behavioral neuroscience
  94. Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide (Anandamide) by Cytochrome P450 Enzymes
    Natasha Tasheva Snider · 2009 · Deep Blue (University of Michigan)
  95. Multiomics machine learning identifies inflammation molecular pathways in prodromal Alzheimer’s Disease
    Gómez-Pascual, Alicia, Naccache, Talel, Xu, Jin, Hooshmand, Kourosh, Wretlind, Asger, Gabrielli, Martina, Lombardo, Marta Tiffany, Shi, Liu, Buckley, Noel J., Tijms, Betty M. et al. · 2023
  96. The Effects of Cannabinoids on Immune Cells, Responses and Diseases
    Cris S. Constantinescu, Radu Tănăsescu · 2012 · Springer eBooks
  97. Exploring the molecular basis to the regulatory effects of Cannabinoids on toll-like receptor signalling
    Eileen Clifford · 2010 · Maynooth University ePrints and eTheses Archive (Maynooth University)
  98. Neuromodulation via endocannabinoids and nitric oxide in the lamprey spinal cord
    Alexandros Kyriakatos · 2009 · Figshare
  99. Role of the Endocannabinoid System in Systems Toxicity
    Constantinos M. Pistos, Stamatios E Theocharis · 2009 · General, Applied and Systems Toxicology
  100. Endocannabinoids as a Target for the Treatment of Traumatic Brain Injury
    Patricia E. Molina · 2012 · Defense Technical Information Center (DTIC)